The global market for cell therapy products derived from stem cells, tissues and organs grown in laboratories and transferred back into patients to stop the progression of diseases and disorders, is growing at a compounded annual growth rate of more than 23%.
As of the end of 2019 there were more than 8,000 active or actively recruiting clinical trials for cell therapies.
In the accelerating race to improve products and gain FDA approval, organizations with promising therapies need an industry-agnostic platform that offers expert resources, modern technologies and flexible services.
Go from Bench to Clinical Production
We offer two GMP suites to help you preprare for clinical trials without incurring the financial risk and extended timeline required to build your own facility.
Our process development lab is equipped with state-of-the-art cell therapy processing technologies to help you move from bench to clinical production.
BioCentriq will augment your in-house process development capacities so you can bring a greater number of projects from preclinical to human trials while avoiding additional capital investment or expensive hires.
Get In Touch
Tell us about your next project or greatest challenge and we'll contact you to discuss how we can help.